Doctor profile · Federal record

Dr. MAYANK AGARWAL, MD

Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Internal Medicine Physician · GALVESTON, TX

  • NPI 1053808261
  • Accepts Medicare
  • 2 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
301 UNIVERSITY BLVD
GALVESTON, TX 775555302
(409) 772-7063
fax (409) 747-8579

Credentials & registration

NPPES · NUCC
NPI registered
April 2018 — 8 yrs on file
Profile last updated
July 19, 2021
Year of graduation
2024 — 2 yrs since
Specialty taxonomy
207RC0000X — NUCC code
State licenses (2)
Texas #BP20077354 · Texas #BP10064492

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1053808261. Last verified May 11, 2026.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,735
Transactions
56
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Boston Scientific Corporation 33 $862.25
Amgen Inc. 5 $270.79
Abbott Laboratories 1 $110.71
PFIZER INC. 2 $110.67
Teleflex LLC 1 $109.58
Merck Sharp & Dohme LLC 3 $56.55
E.R. Squibb & Sons, L.L.C. 2 $38.35
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) 2 $33.81
Ethicon US, LLC 1 $32.76
Esperion Therapeutics, Inc. 1 $21.78
W. L. Gore & Associates, Inc. 1 $21.43
Novo Nordisk Inc 1 $20.17
Lexicon Pharmaceuticals, Inc. 1 $18.25
Boehringer Ingelheim Pharmaceuticals, Inc. 1 $15.02
Janssen Pharmaceuticals, Inc 1 $13.12

By nature of payment

Food and Beverage
$1,735

Hospital affiliations

CMS Hospital Compare